Shinichi Iwasaki
Overview
Explore the profile of Shinichi Iwasaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
183
Citations
1593
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deguchi Y, Iwasaki S, Uesaka Y, Okawa Y, Okura S, Maekubo K, et al.
PLoS One
. 2025 Mar;
20(3):e0319825.
PMID: 40072974
Aims: The aim of this study was to ascertain whether there has been an increase in the number of workers with long-term sickness absence due to mental disorders (LTSA-MD) and...
2.
Xu H, Tong K, Iwasaki N, Ohgami N, Tazaki A, Kagawa T, et al.
J Allergy Clin Immunol Glob
. 2025 Feb;
4(2):100408.
PMID: 39974308
Background: There is no information about the clinical implications and kinetics of zinc (Zn) in the nasal cavity, a center of allergic inflammation, and serum in subjects with allergic rhinitis...
3.
Minakata T, Esaki S, Kabaya K, Katsumi S, Inagaki A, Murakami S, et al.
Auris Nasus Larynx
. 2025 Feb;
52(2):132-136.
PMID: 39893738
Objectives: To investigate the incidence of facial canal dehiscence and its association with the recovery rate of facial palsy in patients with severe Bell's palsy who underwent transmastoid facial nerve...
4.
Fujimoto C, Kawahara T, Kikkawa Y, Kinoshita M, Kamogashira T, Oka M, et al.
PLoS One
. 2025 Jan;
20(1):e0317822.
PMID: 39854562
Objective: This multicenter, randomized, double-blind, placebo-controlled, crossover trial aimed to evaluate whether prolonged noisy galvanic vestibular stimulation improves body balance in patients with vestibulopathy. Materials And Methods: This trial was...
5.
Kabaya K, Takahashi M, Esaki S, Minakata T, Iwasaki S
Otol Neurotol
. 2024 Aug;
45(8):e570-e575.
PMID: 39142307
Objective: To investigate the impact of migraine on the tinnitus-specific health-related quality of life (HRQOL) and psychiatric comorbidities in patients with tinnitus. Methods: This cross-sectional study included 227 consecutive patients...
6.
Sanda N, Sawabe M, Kabaya K, Kawaguchi M, Fukushima A, Nakamura Y, et al.
Laryngoscope Investig Otolaryngol
. 2024 Jul;
9(4):e1297.
PMID: 38974601
Objectives: The aim of present study was to evaluate the clinical efficacy of hyperbaric oxygen therapy (HBOT) as a primary therapy combined with standard systemic corticosteroid treatment for sudden sensorineural...
7.
Tajiri T, Suzuki M, Nishiyama H, Ozawa Y, Kurokawa R, Ito K, et al.
Ann Allergy Asthma Immunol
. 2024 Jul;
133(5):550-558.e2.
PMID: 38972450
Background: Dupilumab exerts clinical effects, including improved sinus opacification, olfactory function, and quality of life, in patients with severe chronic rhinosinusitis with nasal polyps (CRSwNPs). Meanwhile, only a few studies...
8.
Fukushima A, Kabaya K, Minakata T, Katsumi S, Esaki S, Iwasaki S
Front Neurol
. 2024 May;
15:1378206.
PMID: 38708003
Objective: To investigate differences in the clinical characteristics of patients with persistent postural-perceptual dizziness (PPPD) according to age. Methods: We retrospectively reviewed 143 patients diagnosed with PPPD. Patients were classified...
9.
Iwaki S, Kawakita D, Nagao T, Tada Y, Honma Y, Ando M, et al.
Int J Cancer
. 2024 Apr;
155(5):871-882.
PMID: 38686510
Comprehensive information on genetic alterations in salivary gland cancer (SGC) is limited. This study aimed to elucidate the genetic and clinical characteristics of patients with SGC using the Center for...
10.
Tasaki Y, Ito N, Mimura Y, Sugiyama Y, Ogawa R, Shimura T, et al.
Asia Pac J Clin Oncol
. 2024 Apr;
20(4):515-521.
PMID: 38682421
Aim: A new treatment interval for nivolumab administration at 480 mg every 4 weeks, in addition to 240 mg every 2 weeks, was approved in Japan in 2020. Using model-based...